Understanding the Fast-Track Medical Device Registration Process in Indonesia Through a Local Authorised Representative
There is no shortage of opportunity in Indonesia’s healthcare market, but there is a very real shortage of time for foreign exporters entering without a strategy. Indonesia’s demand for medical technology is surging. The national health insurance program (JKN) now covers approximately 90% of the population, and the government’s Cek Kesehatan Gratis (CKG) health screening […]
IVD Registration Indonesia: The Ultimate Guide for American & European Brands
Indonesia’s diagnostics market is growing fast, and foreign brands that move now stand to capture serious ground. But breaking into this market is not simply a matter of having a world-class product. For any American or European manufacturer shipping diagnostic kits, reagents, or analyzers into the Indonesian market, IVD registration Indonesia is a non-negotiable regulatory […]
What Foreign Manufacturers Get Wrong About Indonesia’s Medical Device Market
Most foreign manufacturers who approach Indonesia for the first time come with a plan that has already worked somewhere else. That is usually the first problem. In a recent episode of The Elendi Files, Teddy, General Manager of ElendiLabs, sat down with Dr. Hussein H. Mashhour, MD, Co-founder and COO of Product Registration Indonesia, to […]
National Commitment: Indonesia Targets Cervical Cancer Elimination by 2030 through Integrated DNA HPV Screening
In a major policy reinforcement, our Ministry of Health has reaffirmed its commitment to the global agenda of how Indonesia targets Cervical Cancer elimination by the year 2030. During a high-level forum in Jakarta, Vice Minister of Health Prof. Dante Saksono Harbuwono emphasized that this vision is a critical mission to protect Indonesian women and […]
Strategic Partnership and the Transformation of Digital Health through Medical AI Indonesia-China
Indonesia is entering a new era of healthcare innovation. In a landmark working visit to China, the Indonesian Vice Minister of Health formalized a strategic bilateral cooperation focused on medical AI Indonesia, digital health systems, and the standardization of medical technology. For foreign manufacturers, distributors, and healthcare companies looking to enter Southeast Asia, this partnership […]
Cervical Cancer Screening Gets a Major Upgrade in Indonesia
Cervical cancer Indonesia screening is undergoing one of the most significant transformations in the country’s public health history. Starting in 2026, the Indonesian government is officially integrating cervical cancer screening into its Free Health Check program, widely known as CKG (Cek Kesehatan Gratis). This move is part of a broader national strategy to eliminate cervical […]
Cancer is Curable: Indonesia’s New Healthcare Era Opens Doors for Medical Device Manufacturers
The landscape of oncology in Southeast Asia is shifting. For decades, a cancer diagnosis in Indonesia was often met with fear and a sense of finality. However, the Indonesian Ministry of Health is now championing a transformative message: cancer is curable. During the 2024 World Cancer Day commemorations at Dharmais Cancer Hospital, Health Minister Budi […]
The Evolution of Early Cancer Detection in Indonesia: Driving a New Era in Oncology Care
The landscape of oncology in Southeast Asia is undergoing a profound transformation, with Indonesia standing at the forefront of this shift. As of 2026, the Indonesian government has pivotally redefined its healthcare strategy, moving away from reactive late-stage treatment toward a proactive model centered on early cancer detection in Indonesia. This transition is not merely […]
The Future of Healthcare: Navigating Medical Device Regulatory Services in Indonesia in 2026
The Indonesian healthcare landscape is undergoing a monumental shift. Under the leadership of President Prabowo Subianto, the nation is moving away from a purely curative model toward a proactive, preventive health paradigm. Central to this transformation is the expansion of the Free Health Check (CKG) program, an ambitious initiative aiming to screen nearly half the […]
Regulatory Darwinism and the Indonesia Healthcare Market: Reframing MedTech Capital Strategy for 2026
Beyond the FDA and CE Mark: Why Early Market Entry in the World’s Fourth Most Populous Nation Can Strengthen Valuation and De-Risk Commercialization The 2026 Capital Environment: From Scientific Promise to Industrial Readiness Between 2020 and 2022, venture capital allocation into medical technology was heavily thesis-driven. A strong intellectual property portfolio, compelling preclinical data, and […]